Status: current, Defined. Date: 31-Jul 2008. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3712208016 | Product containing topotecan in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3712209012 | Topotecan-containing product in parenteral dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Topotecan-containing product in parenteral dose form | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
| Topotecan-containing product in parenteral dose form | Is a | Topotecan-containing product | true | Inferred relationship | Some | ||
| Topotecan-containing product in parenteral dose form | Has active ingredient | Topotecan | true | Inferred relationship | Some | 1 | |
| Topotecan-containing product in parenteral dose form | Has manufactured dose form | Parenteral dose form | true | Inferred relationship | Some | ||
| Topotecan-containing product in parenteral dose form | Is a | Product manufactured as parenteral dose form | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Topotecan only product in parenteral dose form | Is a | True | Topotecan-containing product in parenteral dose form | Inferred relationship | Some | |
| Topotecan (as topotecan hydrochloride) 4 mg powder for solution for injection vial | Is a | False | Topotecan-containing product in parenteral dose form | Inferred relationship | Some | |
| Topotecan (as topotecan hydrochloride) 1 mg powder for solution for injection vial | Is a | False | Topotecan-containing product in parenteral dose form | Inferred relationship | Some |
Reference Sets
Australian dialect reference set
FHIR